Corporate Investor

Updated:

BMC Medical

BMC Medical was established in 2001 by Zhi Zhuang, who serves as chairman and holds a 20.76 percent stake. Partners Jin Chun He and Bei Chen function as...

BMC Medical logo

BMC Medical

BMC Medical was established in 2001 by Zhi Zhuang, who serves as chairman and holds a 20.76 percent stake. Partners Jin Chun He and Bei Chen function as directors and senior management with disclosed ownership interests. The company develops respirators, breathing tubes and oxygen generators. It supplies sleep health and respiratory health solutions through direct manufacturing. Confirmed facilities include a Tianjin manufacturing base and a Dongguan production site. In 2017 the firm settled global patent litigation with ResMed under royalty agreements. BMC Medical operates a charitable giving program. Three employees participate as standardization experts in the China Standardization Innovation Strategic Alliance. No additional offices outside China appear in available records. Ownership remains concentrated among the named principals with no disclosed succession vehicle or external fund commitments.

General information

Firm type

Corporate Investor

Year founded

2001

AUM

Undisclosed

Location

Region

Asia

Country

China

City

Beijing

Corporate office

Beijing, China

Additional offices

Tianjin, China · Dongguan, China

Principals

Zhi Zhuang

Chairman

Jin Chun He

Director

Bei Chen

Senior Management

Sector focus

Healthcare Services

Frequently asked questions

Who runs investment decisions at BMC Medical?

Zhi Zhuang as chairman directs capital allocation alongside directors Jin Chun He and Bei Chen.

Does BMC Medical participate in fund commitments or only direct deals?

Available records show only direct manufacturing investments and short-term financial holdings in China.

Where does the underlying wealth come from?

Wealth originates from operations in respiratory medical devices with no external family source disclosed.

What investment stages does BMC Medical typically target?

The firm focuses on internal product development and manufacturing capacity rather than venture or growth equity stages.

How is BMC Medical related to ResMed?

The two firms settled global patent litigation in 2017 involving royalty agreements.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Beijing Corporate Investor profiles